HUE054930T2 - Gyógyszerészeti tramadol készítmény szemészeti alkalmazásra - Google Patents

Gyógyszerészeti tramadol készítmény szemészeti alkalmazásra

Info

Publication number
HUE054930T2
HUE054930T2 HUE16843709A HUE16843709A HUE054930T2 HU E054930 T2 HUE054930 T2 HU E054930T2 HU E16843709 A HUE16843709 A HU E16843709A HU E16843709 A HUE16843709 A HU E16843709A HU E054930 T2 HUE054930 T2 HU E054930T2
Authority
HU
Hungary
Prior art keywords
ophthalmic use
pharmaceutical
composition
tramadol composition
pharmaceutical tramadol
Prior art date
Application number
HUE16843709A
Other languages
English (en)
Inventor
Menendez Nuria Sanz
Cordoba Raquel Horcajada
Fernando Martinez-Alzamora
Vanrell Rocio Herrero
Del Castillo Jose Manuel Benitez
Original Assignee
Farmalider Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmalider Sa filed Critical Farmalider Sa
Publication of HUE054930T2 publication Critical patent/HUE054930T2/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HUE16843709A 2015-09-09 2016-09-05 Gyógyszerészeti tramadol készítmény szemészeti alkalmazásra HUE054930T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES201500657A ES2604816B1 (es) 2015-09-09 2015-09-09 Composición farmacéutica de tramadol para uso oftálmico

Publications (1)

Publication Number Publication Date
HUE054930T2 true HUE054930T2 (hu) 2021-10-28

Family

ID=58208846

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE16843709A HUE054930T2 (hu) 2015-09-09 2016-09-05 Gyógyszerészeti tramadol készítmény szemészeti alkalmazásra

Country Status (11)

Country Link
US (1) US20190224114A1 (hu)
EP (1) EP3348260B1 (hu)
CY (1) CY1124596T1 (hu)
DK (1) DK3348260T3 (hu)
ES (2) ES2604816B1 (hu)
HR (1) HRP20211181T1 (hu)
HU (1) HUE054930T2 (hu)
PL (1) PL3348260T3 (hu)
PT (1) PT3348260T (hu)
RU (1) RU2744570C2 (hu)
WO (1) WO2017042404A1 (hu)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2604816B1 (es) 2015-09-09 2018-01-29 Farmalider, S.A. Composición farmacéutica de tramadol para uso oftálmico
US11103452B2 (en) * 2019-11-08 2021-08-31 Athena Bioscience, Llc Tramadol hydrochloride solution
IT202000015457A1 (it) * 2020-06-26 2021-12-26 Sifi Spa Composizione oftalmica e suo uso nel trattamento di patologie dell’occhio
TW202408472A (zh) * 2022-07-06 2024-03-01 日商樂敦製藥股份有限公司 眼科組成物
WO2024010043A1 (ja) * 2022-07-06 2024-01-11 ロート製薬株式会社 眼科組成物
TW202408467A (zh) * 2022-07-06 2024-03-01 日商樂敦製藥股份有限公司 眼科組成物
WO2024010045A1 (ja) * 2022-07-06 2024-01-11 学校法人金沢医科大学 疼痛抑制剤
TW202408468A (zh) * 2022-07-06 2024-03-01 日商樂敦製藥股份有限公司 眼科組成物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6017963A (en) 1995-11-14 2000-01-25 Euro-Celtique, S.A. Formulation for intranasal administration
US7893040B2 (en) * 2005-07-22 2011-02-22 Oculis Ehf Cyclodextrin nanotechnology for ophthalmic drug delivery
ITMI20052036A1 (it) * 2005-10-26 2007-04-27 Professional Dietetics Srl Composizioni farmaceutiche oftalmiche a base di amminoacidi e sodio ialuronato
KR20140145948A (ko) * 2011-04-05 2014-12-24 옵토솔브 엘엘피 안과 치료제
GB201217522D0 (en) * 2012-10-01 2012-11-14 Sharma Anant ophthalmic therapy
ES2540151B1 (es) * 2013-10-11 2016-02-29 Farmalider S.A. Composición farmacéutica de ibuprofeno y tramadol para uso oftálmico
ES2604816B1 (es) 2015-09-09 2018-01-29 Farmalider, S.A. Composición farmacéutica de tramadol para uso oftálmico

Also Published As

Publication number Publication date
PL3348260T3 (pl) 2021-12-06
EP3348260B1 (en) 2021-06-02
RU2018112239A (ru) 2019-10-09
US20190224114A1 (en) 2019-07-25
ES2604816A1 (es) 2017-03-09
DK3348260T3 (da) 2021-07-05
CY1124596T1 (el) 2022-07-22
ES2882116T3 (es) 2021-12-01
EP3348260A1 (en) 2018-07-18
RU2744570C2 (ru) 2021-03-11
ES2604816B1 (es) 2018-01-29
RU2018112239A3 (hu) 2020-01-30
EP3348260A4 (en) 2019-04-17
WO2017042404A1 (es) 2017-03-16
PT3348260T (pt) 2021-08-06
HRP20211181T1 (hr) 2021-10-15

Similar Documents

Publication Publication Date Title
IL249643A0 (en) Eye preparation
GB201913962D0 (en) Ophthalmic drug compositions
PT3348260T (pt) Composição farmacêutica de tramadol para utilização oftálmica
PL3452075T3 (pl) Oftalmiczna kompozycja farmaceutyczna
GB201619525D0 (en) Ophthalmic composition
RS58971B1 (sr) Kompozicija za okularno zdravlje
SG11201707117SA (en) Ophthalmic composition
IL263040A (en) Pharmaceutical composition comprising eteplirsen
PL3313370T3 (pl) Okulistyczna kompozycja farmaceutyczna
GB201521462D0 (en) Pharmaceutical composition
PL3072503T3 (pl) Kompozycja okulistyczna do ochrony rogówki
GB201515310D0 (en) Pharmaceutical composition
GB201520862D0 (en) Pharmaceutical composition
GB201506755D0 (en) Novel pharmaceutical formulation
SG11201608123VA (en) Pharmaceutical composition for external use
EP3570815C0 (en) COMPOSITION FOR OPHTHALMIC USE
PL3446682T3 (pl) Kompozycja okulistyczna
ZA201703701B (en) Ophthalmic composition
HUE057830T2 (hu) Famitinib tartalmú gyógyszerkészítmény
GB201517133D0 (en) New pharmaceutical use
SG11201608124XA (en) Pharmaceutical composition for external use
SG11201708197QA (en) Pharmaceutical composition for skin
GB201517454D0 (en) New pharmaceutical use
GB201517132D0 (en) New pharmaceutical use
GB201521456D0 (en) Pharmaceutical composition